| Home | Forum | Search |
Paperback: 496 pages Publisher: Atria (September 16 2003) Costumer Rating: Read an Excerpt Foreword Book Description Today, more breast cancer treatment options are available than ever before. But how can you determine the course of action that is right for YOU? Breast Cancer: Beyond Convention is the only single resource that lays out all of the traditional and alternative approaches available today. Assembling a "dream team" of breast cancer experts, the editors of this truly groundbreaking guide encourage readers to work with their practitioners as they consider a variety of approaches, all explained in clear, nontechnical language. Readers will discover
The guide features an encyclopedic appendix of websites, and lists of national support organizations, care centers, recommended audiotapes, CDs, and books — making this the single source to help patients take control of their treatment, assuage their fears, and get them on the road to healing. A portion of the proceeds from the sale of this book will be donated to the Carol Franc Buck Breast Care Center Complementary and Alternative Medicine Program at the University of California, San Francisco. About the Author Mary Tagliaferri, M.D., L.Ac. Mary Tagliaferri, M.D., L.Ac., is one of the founders of the Complementary and Alternative Medicine Program at the University of California, San Francisco's Carol Franc Buck Breast Care Center. She opened the first traditional Chinese medicine clinic at UCSF and has lectured extensively on alternative therapies for treating breast cancer. She is also a breast cancer survivor. » More by Mary Tagliaferri, M.D., L.Ac. Isaac Cohen, M.D. Issac Cohen, O.M.D., L.Ac., is a leading authority in the field of traditional Chinese medicine and menopause treatment. He is a cofounder of the Complementary and Alternative Medicine program at UCSF's Carol Franc Buck Breast Care Center.. » More by Isaac Cohen, M.D. Debu Tripathy, M.D. Debu Tripathy, M.D., is a medical oncologist whose practice and research are dedicated to breast cancer. He has been principal investigator on numerous clinical trials assessing chemotherapeutic and biological oncogene-targeting treatments, and has been a part of a collaborative team designing clinical studies to evaluate herbal therapy approaches for various indications in breast cancer. » More by Debu Tripathy, M.D. | |||||||